Switzerland· 55905001
Valcyte, Filmtabletten
A valganciclovir product, registered in Switzerland by Cheplapharm Schweiz GmbH and dispensed under Swissmedic category A. The same ATC class is registered in 18 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Valganciclovir is registered in 18 of 19 countries.
Countries holding a registration under ATC J05AB14 (valganciclovir), each read from that country’s own register.
- This record: Switzerland
- 11 of them publish a price we can compare per daily dose
Valganciclovir · ATC J05AB14
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of valganciclovir costs, country by country.
Normalised to the WHO defined daily dose (0.9 g), the median price runs from $3.83 in United States to $35.27 in Italy — a ×9.2 gap.
- Switzerland: $35.18 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Valganciclovir · price per daily dose (0.9 g)
USD · FX 28 Sept 2026
- IT Italy$35.27
- CH Switzerland$35.18
- FR France$22.39
- US United States$3.83 (acquisition cost)
The record
At a glance
- Manufacturer
- Cheplapharm Schweiz GmbH
- Country
- Switzerland (CH)
- ATC code
- J05AB14
- ATC class
- Valganciclovir
- Defined daily dose
- 0.9 g, O
- Swissmedic category
- A
- Reimbursed
- No
- Last checked
- June 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
283 interactions on record for valganciclovir.
Graded by severity as the source publishes them — 8 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Valganciclovir · interactions on record
283 records
- 8 severe
- 193 moderate
- 82 info
Most severe, free to view
- CladribineL01BB04severe
- TrospiumA03AB20moderate
- Amphotericin BA07AA07moderate
- TrospiumG04BD09moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under J05AB14
Valganciclovir, as other registers publish it.
- NetherlandsAlvanocyt 450 mg, filmomhulde tablettenZentiva k.s.
- CanadaAURO-VALGANCICLOVIRAURO PHARMA INC
- CanadaAURO-VALGANCICLOVIRAURO PHARMA INC
- PolandCeglarSandoz GmbH
- CzechiaCYTEVIX+pharma arzneimittel gmbh, Graz
- CanadaMINT-VALGANCICLOVIRMINT PHARMACEUTICALS INC
- FranceROVALCYTE 450 mg, comprimé pelliculéCHEPLAPHARM ARZNEIMITTEL (ALLEMAGNE)
- FranceROVALCYTE 50 mg/ml, poudre pour solution buvableCHEPLAPHARM ARZNEIMITTEL (ALLEMAGNE)
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d43da3c0-2578-4746-95d2-9759ccef4a3e GET /v1/drugs/d43da3c0-2578-4746-95d2-9759ccef4a3e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "swissmedic_auth",
"heilmittelcode": "Synthetika"
}See everything about valganciclovir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.